Johns Shelley A, Brown Linda F, Beck-Coon Kathleen, Talib Tasneem L, Monahan Patrick O, Giesler R Brian, Tong Yan, Wilhelm Laura, Carpenter Janet S, Von Ah Diane, Wagner Christina D, de Groot Mary, Schmidt Karen, Monceski Diane, Danh Marie, Alyea Jennifer M, Miller Kathy D, Kroenke Kurt
Indiana University School of Medicine, Indianapolis, IN, USA.
Regenstrief Institute, Inc., 1101 West Tenth Street RF-226, Indianapolis, IN, 46202, USA.
Support Care Cancer. 2016 Oct;24(10):4085-96. doi: 10.1007/s00520-016-3220-4. Epub 2016 May 17.
Cancer-related fatigue (CRF) is a disruptive symptom for many survivors. Despite promising evidence for efficacy of mindfulness-based stress reduction (MBSR) in reducing CRF, no trials comparing it to an active comparator for fatigued survivors have been published. The purpose of this trial was to compare MBSR to psychoeducation for CRF and associated symptoms.
Breast (n = 60) and colorectal (n = 11) cancer survivors (stage 0-III) with clinically significant CRF after completing chemotherapy and/or radiation therapy an average of 28 months prior to enrollment were randomized to MBSR or psychoeducation/support groups (PES). MBSR focused on mindfulness training; PES focused on CRF self-management. Outcomes included CRF interference (primary), CRF severity and global improvement, vitality, depression, anxiety, sleep disturbance, and pain. Outcomes were assessed at baseline (T1), post-intervention (T2), and 6-month follow-up (T3) using intent-to-treat analysis.
Between-group differences in CRF interference were not significant at any time point; however, there was a trend favoring MBSR (d = -0.46, p = 0.073) at T2. MBSR participants reported significantly greater improvement in vitality (d = 0.53, p = 0.003) and were more likely to report CRF as moderately to completely improved compared to the PES group (χ2 (1) = 4.1765, p = 0.041) at T2. MBSR participants also reported significantly greater reductions in pain at T2 (d = 0.53, p = 0.014). In addition, both MBSR and PES produced moderate-to-large and significant within-group improvements in all fatigue outcomes, depression, anxiety, and sleep at T2 and T3 compared to T1.
MBSR and PES appear efficacious for CRF and related symptoms. Larger trials including a usual care arm are warranted.
ClinicalTrials.gov Identifier: NCT01724333.
癌症相关疲劳(CRF)是许多幸存者面临的一个干扰性症状。尽管有证据表明基于正念减压疗法(MBSR)在减轻CRF方面具有显著疗效,但尚未有将其与针对疲劳幸存者的积极对照进行比较的试验发表。本试验的目的是比较MBSR与针对CRF及相关症状的心理教育。
乳腺癌(n = 60)和结直肠癌(n = 11)幸存者(0 - III期),在入组前平均28个月完成化疗和/或放疗后出现具有临床意义的CRF,被随机分为MBSR组或心理教育/支持组(PES)。MBSR组专注于正念训练;PES组专注于CRF自我管理。结局指标包括CRF干扰(主要指标)、CRF严重程度和整体改善情况、活力、抑郁、焦虑、睡眠障碍和疼痛。在基线(T1)、干预后(T2)和6个月随访(T3)时使用意向性分析评估结局指标。
在任何时间点,两组在CRF干扰方面的组间差异均不显著;然而,在T2时存在有利于MBSR组的趋势(d = -0.46,p = 0.073)。与PES组相比,MBSR组参与者在活力方面的改善显著更大(d = 0.53,p = 0.003),并且在T2时更有可能报告CRF为中度至完全改善(χ2(1) = 4.1765,p = 0.041)。MBSR组参与者在T2时报告的疼痛减轻也显著更大(d = 0.53,p = 0.014)。此外,与T1相比,MBSR组和PES组在T2和T3时在所有疲劳结局、抑郁、焦虑和睡眠方面均产生了中度至大幅且显著的组内改善。
MBSR和PES对CRF及相关症状似乎有效。有必要开展包括常规护理组的更大规模试验。
ClinicalTrials.gov标识符:NCT01724333。